Morgan Stanley ( NYSE:MS ), the stalwart of Wall Street, delivered a resounding victory in its first-quarter earnings report, surpassing analyst expectations and igniting a 3.7% surge in its shares. Buoyed by a robust resurgence in investment banking activities and impressive growth in wealth management, the bank's stellar performance underscored its resilience...
ROCKET COMPANIES NYSE:RKT - Apr. 5th, 2024 BUY/LONG ZONE (GREEN): $13.55 - $14.75 DO NOT TRADE/DNT ZONE (WHITE): $12.80 - $13.55 SELL/SHORT ZONE (RED): $11.50 - $12.80 Weekly: Bullish Daily: DNT 4H: Bearish The weekly timeframe has a bullish trend with strong bearish momentum on the most recent candle as the week is wrapping up. The daily timeframe has a...
UnitedHealth Group ( NYSE:UNH ), the titan of the health insurance industry, emerged triumphant in the face of daunting challenges as it delivered a stellar performance in its first-quarter earnings update. Despite grappling with a surge in medical payouts and the financial fallout from a crippling cyberattack, UnitedHealth's resilience shone through, propelling...
Always good to measure against the DXY not just the USD value Not perfect of course as it is mainly the Euro and Yen but still insightful. Been watching the relationship for a while currently breaking out to the upside HVF theory means this should be a violent expansion Target 1 coming up.
April 15th is a significant date in the US tax calendar. Investors balance portfolios before this date, often capital losses are realised to offset gains. Rivian would be a prime candidate in this scenario, if you believe the company will be still around in 5 years this could be time to buy
Sold 490 puts for 5/3/24 expiration, with 17 DTE. We may touch it, but doubtful. Also short 530 calls, but I sold them with 28 DTE, whenever that was. Almost out of juice at this point, might buy them back to lock in my gain and free up some capital.
Intra-Cellular Therapies ( NASDAQ:ITCI ) witnessed a sharp increase in its stock value, as it surged by 25% on Tuesday, following the success of its drug Caplyta in a depression treatment study. The drug has already been approved for the treatment of schizophrenia and depressive episodes in bipolar disorder patients, and the recent study has indicated its...
Crude Oil (May) Yesterday’s close: Settled at 85.41, down 0.25 Crude Oil futures have traded in a quiet range, going back through last week, outside of an early Friday morning geopolitical spike. A slate of economic data from China last night printed better Q1 GDP results at 5.3% versus 4.8%, but Industrial Production and Retail Sales whiffed. However, U.S....
Gold (June) / Silver (May) Gold, yesterday’s close: Settled at 2383.0, up 8.9 Silver, yesterday’s close: Settled at 28.717, up 0.387 Gold futures traded above $2400 and Silver above $29 early in the session but did see a wave of profit taking through the thick of European hours, but are attempting to stabilize ahead of the U.S. bell. The construction off...
Topicus is a spinoff of the famous constellation software, but in europe. Constellation has some of the best business practices in the world. They also have some of the best practices to protect and grow shareholder value. Topicus focuses on buying software companies for a variety of different market sectors. This strategy is proven and provides tremendous...
This could be forming a H&S bottom. Zero talk about it. Could reflation move be peaking? Are we in a recession or soon to be?
HYG broke its' 200 mda - RUT is following HYG down. RUT will likely follow it through the 200mda unless the Plunge Protection Team at the Federal Reserve comes to save it.
Hi folks given that Bit farms is under a bearish order block and is below VAH with the stochastic RSI falling I am expecting the price to touch the POC of around $1.60 where buyers should step back in. I believe a shakeout is taking place so the big institutions can buy at better prices probably the POC level before the price turns bullish again which it should...
Walgreens Boots Alliance shares have now dipped into our Target Zone between $19.29 and $16.53. Here we expect the end of the blue wave (II) and thus a reversal. Traders could open long positions within the range, with stops about 1% below the lower edge.
In a bold strategic maneuver, Salesforce.com ( NYSE:CRM ) finds itself at the precipice of a transformative acquisition, with reports emerging of advanced discussions to acquire data-management software powerhouse Informatica (INFA). As the rumor mill churns and investors brace for potential ripple effects, the landscape of cloud computing and artificial...
WATCH SUPPORT LEVELS TO PAY ATTENTIO! Short Term Price Target $155.27 to 146.54 1. Tesla's Stock Price Below $100.00: The fact that Tesla's stock could drop below $100.00 suggests a significant bearish sentiment in the market. Investors may be concerned about the company's performance or broader economic factors impacting the stock. 2. Possibility of Dropping...
GME Why hasn’t #Wallstreetbets save their fanboys? GME Weekly chart analysis Let’s compare 2021 vs 2022 Pretty clear and straight forward. 2021 Two green weeks mid Jan.’21 sent price flying from 9.75 to high of about 120.65. Since then, GME has done nothing but make a series of Lower Highs into Support area @ 37.95-45.55. These Lower highs into support area...